November 21, 2009



Advertisement



Going Home

By Barry Yeoman, January & February 2005


Page 1  |  2  |  3  |  4  |  5  |  6 »


Jack Smith was lucky, both to get into a hospice program and to reap its benefits for a full month. For all of the hospice movement's growth, it still reaches only one in four dying Americans, and in many places considerably fewer. A terminally ill patient in Portland, Maine, for example, is less than one tenth as likely to use hospice as someone in Fort Lauderdale, Florida. There are many reasons for these variations. Florida has a state licensing process that encourages large hospice organizations with the resources to advertise, do community outreach, and build relationships with doctors and hospitals. Maine has no similar process.

Ironically, when it comes to access, big cities aren't always the best. New York, for example, has some of the lowest hospice rates in the country. "It has something to do with a very academic and highly advanced health-care system," says Carolyn Cassin, director of Jacob Perlow Hospice at New York's Beth Israel Medical Center. "There's more health care here than anyone can consume." Big-city doctors are so enamored of the medical razzle-dazzle available to them that they often don't refer patients to hospice. "In 2002, 12.8 percent of patients who died of terminal illnesses in New York were assessed suitable for hospice," Cassin says. "Shameful! It should be up in the 60 percent range."

AARP: Lifestyle Information for People 50 and Over
The entertaining and informative content on AARPmagazine.org is just one of the many benefits of AARP membership—only $12.50 a year. Join or renew online today!

Even for those who make it into hospice, there's a trend toward shorter enrollments. In 1992, 21 percent of all hospice patients died within one week of admission; a decade later, the figure had climbed to 35 percent. "One of the saddest things is when we have a patient who could have benefited from the hospice program for several months—but by the time the doctor makes the referral, they only live three or four days," says psychologist Dana Cable, Ph.D., board president of Maryland's Hospice of Frederick County. "That's not enough time to get them into pain control and to work with the family to help them cope with death."

Why are so many people steering clear of hospice or waiting until their final days? Like Peggy Smith, many relatives equate hospice with "giving up." Or like Danielle Carpenter, they don't want to forfeit that one last shot. But patient and family attitudes are only a small part of the problem: there's a whole set of barriers, from physician training to federal-funding formulas, that combine to depress the level of hospice use in the United States.

Leading the list of obstacles are doctors themselves. They control a medical system that is focused on curing disease, not comforting the ailing. Today's physicians control medical school curricula, so tomorrow's doctors receive little or no training in end-of-life care. "Only when the patient is days before dying does anyone think, oh, maybe we should call hospice," says Betty Ferrell, Ph.D., a research scientist at the City of Hope National Medical Center in Los Angeles. "Physicians need to learn how to say, 'You know, your mother has had a rough last few months. I, like you, am hopeful. However, I'd like us to consider what her care might be if she continues on this course.' "

While many medical schools have started teaching palliative care, many experts agree they still have a long way to go. Even after a doctor graduates, the opportunities to learn about end-of-life care remain sparse. Says Fox Chase's Levy: "Most doctors aren't trained in how to sit down with a patient and talk about the difficult realities of what science has to offer."

Physicians, of course, are human. Telling patients that they're dying is a gut-wrenching process, and many doctors will postpone the conversation as long as possible. So even those doctors who are well-trained find themselves faltering. "Some patients become these sequoias, the pillars of our clinical practice," says Christopher Daugherty, M.D., a clinical oncologist and medical ethicist at the University of Chicago. "You become more hesitant with those patients to disclose bad news. It happened to me yesterday: one of my patients with advanced leukemia was visiting the hospital, and I knew that I needed to see her. There was a perfect opportunity to say, 'There is no more therapy I can give you.' But I didn't have the guts and fortitude. Who wants to give bad news?"


Page 1  |  2  |  3  |  4  |  5  |  6 »